Clinical Trial Detail

NCT ID NCT03156114
Title This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Boehringer Ingelheim
Indications

Advanced Solid Tumor

non-small cell lung carcinoma

follicular lymphoma

Therapies

BI 754091

BI 754111

Age Groups: adult senior

Additional content available in CKB BOOST